Previous Article | Next Article 
Infection and Immunity, April 2001, p. 2372-2377, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2372-2377.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Influence of Major Histocompatibility Complex on
Bacterial Composition of Fecal Flora
Paavo
Toivanen,*
Jussi
Vaahtovuo, and
Erkki
Eerola
Department of Medical Microbiology, Turku
Immunology Centre, Turku University, FIN-20520 Turku, Finland
Received 1 August 2000/Returned for modification 8 November
2000/Accepted 11 January 2001
 |
ABSTRACT |
Very little is known about how the host genome influences the
composition of the gastrointestinal flora, largely due to the great
number and diversity of bacteria present in the flora and the
difficulties of using traditional methods of bacterial isolation and
identification. We have approached the problem by studying bacterium-derived cellular fatty acids in the stool samples of six
mouse strains congenic for the major histocompatibility complex (MHC).
The results obtained indicate that the composition of the fecal flora
is genetically regulated. In addition to undefined gene loci, MHC alone
has a pronounced effect, since mice with different MHC in the same
background have significantly different fecal floras. Demonstration of
the genetic influence on the gastrointestinal flora opens a new
approach to studying the pathogenesis of bacterially induced diseases.
 |
INTRODUCTION |
Gastrointestinal flora plays an
important role in the health and disease of the host. It is a complex
ecosystem with great metabolic activity, consisting in humans of 1.0 to
1.5 kg of bacterial mass, 1011 to 1012
individual bacteria per g, and 400 to 500 different species (14, 17, 18, 36). Most of the bacterial species in the gut are anaerobic, and many of them have not been identified, due to
insensitivity of bacterial cultures. The composition of the intestinal
flora remains stable over long periods of time, but differences between individuals may be significant, even for those living in close proximity. Several exogenous factors contribute to the stability and
changes of the flora. Its content is known to be affected by diet,
medical treatment, and stress. Also, in several disease conditions,
including Crohn's disease and rheumatoid arthritis, an altered
intestinal flora has been reported (5, 9, 14). The only
available evidence for a role of other endogenic factors comes from a
twin study; by using anaerobic bacterial cultures, it has been shown
that fecal floras of monozygotic twins are more similar with each other
than those of dizygotic twins (38). Recently we have
demonstrated that mice of different inbred strains differ in
composition of the fecal flora (37a).
The traditional methods of studying gastrointestinal flora include
isolation, identification, and enumeration of different bacterial
species. The enormous amount of various bacteria makes isolation and
identification of the different species, even in a single stool sample,
an extremely laborious task, demanding at least 1 person-year of
laboratory work. Even then, the classical culture methods are
insensitive, difficult to interpret, and poorly reproducible
(35). Some intestinal bacteria do not grow in vitro. Some
grow only on selective media, and many prevent growth of other species,
making reproducibility of the traditional methods quite poor. For these
reasons, classical bacteriological techniques are unsuitable for
studies of fecal microecology (7).
Instead of focusing on specific bacterial species, we have used another
approach to detect overall differences in the gut flora. This has been
made possible by computerized comparison of bacterial cellular fatty
acid (CFA) profiles produced by gas-liquid chromatography (GLC)
directly from the stool samples. The CFAs are structural components of
bacterial cell membranes. They are nonvolatile and contain long-chain
fatty acids with a typical composition for each bacterial species
(3, 10, 19, 22). Thus, the CFA profile of a stool sample
represents all bacteria present in the sample. The GLC method is
especially useful when the number of samples is large. It has proved to
be considerably more sensitive than traditional methods in detecting
microecological changes in the stool (4, 6, 24-29). In
the present work, we used GLC to demonstrate that composition of the
murine fecal flora is genetically regulated, with a pronounced
influence of the major histocompatibility complex (MHC).
 |
MATERIALS AND METHODS |
Mice.
Four-week-old male mice were purchased from Jackson
Laboratory (Bar Harbor, Maine). Half of the mice were from three
congenic strains with an A background genotype and different only in
the MHC (H-2) as follows: A.BY
(H-2b), A.CA (H-2f), and
A.SW (H-2s). The other half were from three
congenic strains with a C57BL background as follows: C57BL/10J
(H-2b), B10.M (H-2f), and
B10.S (H-2s). The strains with the same
background genotype differ from each other only in the MHC-encoded
genes. From each strain, six to eight mice were used. In the supplying
laboratory, the mice were housed in identical environments and fed with
autoclaved NIH-31 6% fat diet (Purina Mills, Inc., Richmond, Ind.).
The same diet had been in use for 2 years for the previous generations
of these mouse strains. In our laboratory, all mice were fed autoclaved R36 diet (Lactamin AB, Södertälje, Sweden), slightly
different from the diet given in the supplying laboratory. The mice
were housed individually in Macrolon I cages with free access to
distilled water. Autoclaved aspen beddings were changed once a week.
All mice were handled identically, with only two persons participating throughout the experiment, which was carried out simultaneously with
the six mouse strains. In addition, stool samples of four C57BL/B6
germ-free mice obtained from the Laboratory of Medical Microbial
Ecology, Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden, were used. The animal experiments were
carried out in concordance with the national and international laws and
policies (order no. 1076/85, Government of Finland; EEC Council
Directive 86/609, OJL 358, December 1987).
Stool samples.
Stool samples from the rectum were collected
at appropriate intervals and stored immediately at
70°C. Before GLC
analysis, the stool samples were processed to separate bacterial mass
from other fecal material. First, fibrous material from the diet and eukaryotic cells were allowed to sediment. For this, 100 mg of the
fecal sample was suspended in 5 ml physiological saline, gently mixed,
and allowed to stand for 2 h at 4°C; thereafter, the sample was
remixed and allowed to sediment for 15 min. The supernatant which
contains the free fatty acids, fragments of eukaryotic and prokaryotic
cell membranes, and whole bacterial cells was then centrifuged
(1,000 × g, 15 min) to separate bacterial cells as a
pellet. The method effectively separates bacterial mass from other
fatty acids present in the feces (23).
For GLC, the separated bacterial mass was saponified and methylated as
described elsewhere (3). In brief, the bacterial mass was
incubated for 30 min at 100°C with 15% (wt/vol) NaOH in 50% aqueous
methanol and then acidified to pH 2.0 with 6 N aqueous HCl in
CH3OH. The methylated fatty acids were then extracted with
ethyl ether and hexane.
GLC.
GLC analysis was performed with an HP6890 PLUS gas
chromatograph (Hewlett-Packard) and an HP-Ultra 2 column of
cross-linked 5% phenylmethyl silicone (length, 25 m; inner diameter,
0.2 mm; film thickness, 0.33 µm). Ultra-high-purity helium was used
as a carrier gas. The GLC settings were as follows: injection port temperature, 250°C; detector temperature, 300°C; initial column temperature, 170°C, increasing at 5°C/min up to 270°C at 20 min; total analysis time, 25 min; sample volume, 1 µl. The chromatograms obtained are bacterium-derived CFA profiles of the samples analyzed.
Data analysis.
The GLC data analysis is based on
computerized comparison of bacterial CFA profiles. Each bacterial
species has a typical CFA composition. The CFA profile of bacterial
mass in a stool sample represents all bacteria present. Thus, two
samples with identical microbial flora yield identical CFA profiles.
This type of analysis followed by a cluster analysis reveals which
samples are similar to each other and the relative similarity of the
samples. A bacterial identification program developed previously
(3) was used to analyze the GLC data of stool samples
containing several bacterial species. All identified and unidentified
peaks of individual fatty acids in the chromatograms were used in the
analyses. All samples were compared to each other, and similarity
indices (with a scale of 0 to 100) were calculated for each sample pair
and between the groups. The calculation program (3)
identifies the chromatogram peaks according to the retention time.
Those with the same retention time are compared according to the size, reflecting amount of the fatty acid; an index of 100 is given to a pair
with the same size, and that of 0 if the other peak is completely
missing. A similarity index for a sample pair is obtained by
calculating a weighted (according to the sizes of the peaks) average of
the peak indices. The same principle is used to calculate a similarity
index when two groups (clusters) of samples are compared with each
other. An index of 100 indicates complete similarity with same fatty
acids (peaks in the chromatogram) found in the same amount in the
samples compared; an index of 0 indicates complete dissimilarity.
To calculate the statistical significance of a difference between two
groups, the variation of the CFA profiles within each
group was
compared to the variation between these groups. The
variation within a
group was determined by calculating the mean
± standard deviation
(SD) for all paired comparisons within the
group. The variation between
two groups was calculated by comparing
each CFA profile in one group to
all profiles in the other group.
The mean ± SD was calculated for
all of these comparisons. Finally,
the variation between the groups
(mean
x, SD
s, number of comparisons
n) was compared to the variation within the groups
(
x1,
s1, and
n1 for the first group;
x2,
s2, and
n2 for the second
group) by
calculating a
z value as follows:
The value obtained was used to determine the
P value from the
z table (
1).
 |
RESULTS |
Figure 1 presents stool CFA profiles of a conventionally housed
mouse and a germ-free mouse from the samples processed identically. To
exclude any eukaryotic contribution, the soluble material and the
fibrous parts derived from the diet and host cells were removed from
the stool samples (23), and only a few negligible peaks were observed in the CFA profile of the germ-free stool. However, the
sterile food pellets appeared rich in gram-positive bacteria when
stained. The same, though to a considerably lesser extent, was observed
for the germ-free stools. In the chromatographic analysis, the food
pellets yield exactly the same few peaks as the germ-free stool samples
(Fig. 1), indicating that the small peaks
in the chromatogram of the germ-free stool are derived from the dead
bacteria present in the sterile food pellets. On these bases, we
conclude that only fatty acids derived from bacteria in the stool are
included in the GLC analyses.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
GLC analysis of CFAs from stool samples of a
conventionally housed mouse and a germ-free mouse. The samples were
processed identically. Each peak represents a fatty acid. Also
presented is the CFA profile of sterile food pellets used for the
germ-free mice, processed similarly to the stool samples. When stained,
both the sterile food pellets and germ-free stool were found to contain
gram-positive bacteria.
|
|
To study the influence of MHC, 10 stool samples were collected from
each mouse at intervals of 1 to 4 weeks. CFA profiles of the samples
appear considerably homogeneous when the samples collected at each time
point are compared within the mouse strains (Fig.
2). Comparisons between strains congenic
for the MHC and carrying different H-2 genotypes (b,
f or s) reveal an effect of the MHC on the fecal flora.
When mice with different H-2 genotypes in the A background
are compared, statistically significant differences in the CFA profiles
are observed on all occasions throughout the study, from 5 to 24 weeks
of age, the only exception being at 11 weeks of age (Table
1). Similar results are observed when mice with the C57BL background and s genotype are compared
to those with b or f genotype in the same
background, revealing statistically significant differences on 17 occasions out of 20. In the comparison between the b and
f genotypes in the C57BL background, the differences are
statistically significant for the samples collected at 5, 7, and 9 weeks of age.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 2.
Example of cluster analysis with CFA profiles from stool
samples of A.CA (H-2f), A.BY
(H-2b), and A.SW (H-2s)
mice, taken at 7 weeks of age. Each figure within the H-2
genotypes indicates a sample from one mouse. All 19 samples are
compared to each other and clustered according to similarity. An index
of 100 indicates complete similarity with the same fatty acids (peaks
in the chromatogram) found in the same concentrations in the samples
compared; an index of 0 indicates complete dissimilarity. Stool CFA
profiles from mice with different H-2 genotypes form
separate clusters revealing considerable homogeneity within each
genotype. Position of the vertical lines on the scale indicates
similarity between the samples or between the clusters. Differences
between the clusters (H-2 genotypes) are statistically
significant (P 0.001).
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Comparison of fecal floras from mice with different
H-2 genotypes in the same background and from mice with
the same H-2 genotype in a different background
|
|
The results obtained indicate that MHC-encoded genes have a clear-cut
contribution to the composition of the murine fecal flora. However, it
is apparent that the genes outside the MHC also have an effect, since
fecal floras of mice with the same H-2 genotype in a
different background differ significantly from each other. This is
revealed by all three H-2 genotypes used; there is only one
exception among the 30 comparisons made (Table 1). Therefore, it is
understandable that mice which differ in both MHC and background have
significantly different intestinal floras; only three exceptions
occurred among the 60 comparisons made (Table
2).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Comparison of fecal floras from mice with different
H-2 genotypes in a different background (A or C57BL)
|
|
All mice, including their mothers and ancestors in the previous 2 years, had been on the same diet in the supplying institution. At
arrival in our laboratory, they were all simultaneously changed to a
slightly different diet. Therefore, any maternal or environmental contribution to the differences observed between the mouse strains can
be excluded. We conclude that MHC-encoded genes have a significant influence on the composition of the fecal flora. In addition, genes
outside the MHC also have an impact, as revealed by the comparisons
made between mice having the same H-2 genotype in a
different background. It is possible that the undefined genes of the
C57BL background have a more profound effect than those of the A
background, since the differences between b and f
genotypes of mice with C57BL background are considerably less
frequently significant than the others (Table 1). However, the present
data do not allow any conclusions about the relative size of the MHC and non-MHC contributions.
 |
DISCUSSION |
The mechanisms behind the effect of MHC on the bacterial flora
remain open. Class I and II MHC molecules are highly polymorphic transmembrane glycoproteins of eukaryotic cells; class I molecules are
present on the surface of all nucleated cells. The basic structure of
MHC molecules consists of domains exhibiting the typical immunoglobulin (Ig) fold, and they function as key elements of the immune response by
presenting peptides to T cells. Therefore, the most obvious alternative
to explain the influence of MHC on the fecal or intestinal flora would
be the immune elimination of certain bacterial species, leading to a
restricted colonization. However, very little is known about the effect
of MHC on antibacterial responses (14, 37). One should
also note that bacterial composition of the murine fecal flora does not
necessarily indicate the exact composition of the intestinal flora
(31, 36).
An alternative mechanism is an action through bacterial adherence to
intestinal epithelial surfaces that is a requisite first step in the
colonization process. Bacterial surface molecules, adhesins, recognize
proteins or glycoproteins on the epithelial cells. Bacteria unable to
adhere are shed. The specificity of the adherence leads to a restricted
colonization of the host. As an example, attachment of
Helicobacter pylori to human gastric epithelium is
selectively mediated by blood group antigen Lewisb
(2). Regarding MHC molecules and bacterial adherence,
several Ig-binding proteins have been demonstrated on the bacterial
surfaces. One type of these, fibrous proteins called curli, have been
shown to interact with the Ig-like domains of human class I MHC
molecules (21). The effect of different MHC genotypes was
not studied. However, Helicobacter felis-induced gastric
inflammation, which depends on the bacterial attachment and
colonization, varies in severity in congenic mice with different MHC
(16). In addition to a twin study on the intestinal flora
(38), it has been reported that bacterial flora of the
nasal epithelium could be genetically controlled (8). It
remains to be established whether MHC influences intestinal
colonization through the immune response or by directly affecting
bacterial adhesion. The latter possibility could be mediated by MHC
molecules as such or by other structures encoded by MHC
(15).
Demonstration of the genetic influence on the gastrointestinal flora
opens a new perspective to study the pathogenesis of bacterially
induced diseases, also including autoimmune and other disorders. For
instance, the intestinal flora in patients with newly diagnosed
rheumatoid arthritis is significantly different from that in the
controls (4), and it is known that rheumatoid arthritis is
preferentially associated with certain MHC genotypes (20,
39). Further, cell walls of several bacterial species of the
normal human gut flora are capable of inducing experimental chronic
polyarthritis (33, 34, 40); on the other hand, degradation products of intestinal bacteria enter the circulation and joint tissue
quite often (11-13, 30, 32). Maybe individuals with certain genotypes are intestinally colonized by bacteria which have
cell walls capable of inducing arthritis. In the long run, with
continuous seeding of bacterial degradation products from the gut, the
synovial inflammation is maintained and is followed by erosion,
exposure of cartilage antigens, and autoimmunity. It must be remembered
that bacteria in the intestinal flora are continuously dividing and
degraded, resulting in an enormous amount and variety of
bacterial products.
 |
ACKNOWLEDGMENTS |
Stool samples of germ-free mice were kindly provided by Elisabeth
Norin, Laboratory of Medical Microbial Ecology, Department of Cell and
Molecular Biology, Karolinska Institute, Stockholm, Sweden. We thank
Pavol Ivanyi and Olli Vainio for comments on the manuscript.
This work was supported by a grant from EVO of Turku University Central Hospital.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology, Turku University, FIN-20520 Turku, Finland.
Phone: 358-2-333-7426. Fax: 358-2-233-0008. E-mail:
paavo.toivanen{at}utu.fi.
Editor:
: J. T. Barbieri
 |
REFERENCES |
| 1.
|
Altman, D. G.
1996.
Practical statistics for medical research.
Chapman & Hall, London, England.
|
| 2.
|
Borén, T.,
P. Falk,
K. A. Roth,
G. Larson, and S. Normark.
1993.
Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.
Science
262:1892-1895[Abstract/Free Full Text].
|
| 3.
|
Eerola, E., and O. P. Lehtonen.
1988.
Optimal data processing procedure for automatic bacterial identification by gas-liquid chromatography of cellular fatty acids.
J. Clin. Microbiol.
26:1745-1753[Abstract/Free Full Text].
|
| 4.
|
Eerola, E.,
T. Möttönen,
P. Hannonen,
R. Luukkainen,
I. Kantola,
K. Vuori,
J. Tuominen, and P. Toivanen.
1994.
Intestinal flora in early rheumatoid arthritis.
Br. J. Rheumatol.
33:1030-1038[Abstract/Free Full Text].
|
| 5.
|
Eerola, E., and R. Peltonen.
1998.
The gastrointestinal system, p. 255-277.
In
P. J. Maddison, D. A. Isenberg, P. Woo, and D. N. Glass (ed.), Oxford textbook of rheumatology, 2nd ed., vol. 1. Oxford University Press, Oxford, England.
|
| 6.
|
Grönlund, M. M.,
O. P. Lehtonen,
E. Eerola, and P. Kero.
1999.
Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery.
J. Pediatr. Gastroenterol. Nutr.
28:19-25[CrossRef][Medline].
|
| 7.
|
Hill, M., and B. S. Drasar.
1975.
The normal colonic bacterial flora.
Gut
16:318-323[Free Full Text].
|
| 8.
|
Hoeksma, A., and K. C. Winkler.
1963.
The normal flora of the nose in twins.
Acta Leiden.
32:123-133.
|
| 9.
|
Holdeman, L. V.,
I. J. Good, and W. E. C. Moore.
1976.
Human fecal flora. Variation in bacterial composition within individuals and a possible effect of emotional stress.
Appl. Environ. Microbiol.
31:359-375[Abstract/Free Full Text].
|
| 10.
|
Kotilainen, P.,
P. Huovinen, and E. Eerola.
1991.
Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci.
J. Clin. Microbiol.
29:315-322[Abstract/Free Full Text].
|
| 11.
|
Lehtonen, L.,
E. Eerola,
P. Oksman, and P. Toivanen.
1995.
Muramic acid in peripheral blood leukocytes of healthy human subjects.
J. Infect. Dis.
171:1060-1064[Medline].
|
| 12.
|
Lehtonen, L.,
E. Eerola, and P. Toivanen.
1997.
Muramic acid in human peripheral blood leucocytes in different age groups.
Eur. J. Clin. Investig.
27:791-792[CrossRef][Medline].
|
| 13.
|
Lehtonen, L.,
P. Kortekangas,
P. Oksman,
E. Eerola,
H. Aro, and A. Toivanen.
1994.
Synovial fluid muramic acid in acute inflammatory arthritis.
Br. J. Rheumatol.
33:1127-1130[Abstract/Free Full Text].
|
| 14.
|
Mackie, R. I.,
B. A. White, and R. E. Isaacson.
1997.
Gastrointestinal microbiology, vol. 2. Gastrointestinal microbes and host interactions.
Chapman & Hall, New York, N.Y.
|
| 15.
|
The MHC Sequencing Consortium.
1999.
Complete sequence and gene map of a human major histocompatibility complex.
Nature
401:921-923[CrossRef][Medline].
|
| 16.
|
Mohammadi, M.,
R. Redline,
J. Nedrud, and S. Czinn.
1996.
Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains.
Infect. Immun.
64:238-245[Abstract].
|
| 17.
|
Moore, W. E. C., and L. V. Holdeman.
1974.
Human fecal flora: the normal flora of 20 Japanese-Hawaiians.
Appl. Microbiol.
27:961-979[Medline].
|
| 18.
|
Moore, W. E. C., and L. V. Holdeman.
1974.
Special problems associated with the isolation and identification of intestinal bacteria in faecal flora studies.
Am. J. Clin. Nutr.
27:1450-1455[Medline].
|
| 19.
|
Moss, C. W., and O. L. Nunez-Montiel.
1982.
Analysis of short-chain acids from bacteria by gas-liquid chromatography with a fused-silica capillary column.
J. Clin. Microbiol.
15:308-311[Abstract/Free Full Text].
|
| 20.
|
Nepom, G. T.
1998.
Major histocompatibility complex-directed susceptibility to rheumatoid arthritis.
Adv. Immunol.
68:315-332[Medline].
|
| 21.
|
Olsén, A.,
M. J. Wick,
M. Mörgelin, and L. Björck.
1998.
Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules.
Infect. Immun.
66:944-949[Abstract/Free Full Text].
|
| 22.
|
Onderdonk, A. B., and M. Sasser.
1995.
Gas-liquid and high-performance liquid chromatographic methods for the identification of microorganisms, p. 123-129.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
|
| 23.
|
Peltonen, R.
1994.
Studies on faecal microecology with reference to diet, medication and rheumatoid arthritis.
Ann. Univ. Turku.
143:1-96.
|
| 24.
|
Peltonen, R., and E. Eerola.
1992.
Direct automatic bacterial analysis of rat stools samples; the effects of diet and medical treatment studied by computerised gas-liquid chromatography of bacterial fatty acid.
Microb. Ecol. Health Dis.
5:93-103.
|
| 25.
|
Peltonen, R.,
E. Eerola,
K. Suomi,
H. Aho,
M. Kuusisto, and P. Toivanen.
1993.
Effect of dietary fish powder on intestinal flora and development of arthritis in the pig.
Br. J. Rheumatol.
32:1049-1054[Abstract/Free Full Text].
|
| 26.
|
Peltonen, R.,
J. Kjeldsen-Kragh,
M. Haugen,
J. Tuominen,
P. Toivanen,
Ö. Förre, and E. Eerola.
1994.
Changes of faecal flora in rheumatoid arthritis during fasting and one-year vegetarian diet.
Br. J. Rheumatol.
33:638-643[Abstract/Free Full Text].
|
| 27.
|
Peltonen, R.,
W. H. Ling,
O. Hänninen, and E. Eerola.
1992.
An uncooked vegan diet shifts the profile of human fecal microflora: computerized analysis of direct stool sample gas-liquid chromatography profiles of bacterial cellular fatty acids.
Appl. Environ. Microbiol.
58:3660-3666[Abstract/Free Full Text].
|
| 28.
|
Peltonen, R.,
M. Nenonen,
T. Helve,
O. Hänninen,
P. Toivanen, and E. Eerola.
1997.
Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet.
Br. J. Rheumatol.
36:64-68[Abstract/Free Full Text].
|
| 29.
|
Peltonen, R.,
P. Toivanen, and E. Eerola.
1993.
Effect of a non-steroidal anti-inflammatory drug, naproxen, on faecal microbial flora.
Br. J. Rheumatol.
32:996-999[Abstract/Free Full Text].
|
| 30.
|
Salmi, M., and S. Jalkanen.
1997.
How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing.
Adv. Immunol.
64:139-218[Medline].
|
| 31.
|
Savage, D. C.
1977.
Microbial ecology of the gastrointestinal tract.
Annu. Rev. Microbiol.
31:107-133[CrossRef][Medline].
|
| 32.
|
Schrijver, I. A.,
M.-J. Melief,
P. P. Tak,
M. P. Hazenberg, and J. D. Laman.
2000.
Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines.
Arthritis Rheum.
43:2160-2168[CrossRef][Medline].
|
| 33.
|
Severijnen, A. J.,
R. van Kleef,
M. P. Hazenberg, and J. P. van de Merwe.
1989.
Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats.
J. Rheumatol.
16:1061-1068[Medline].
|
| 34.
|
Simelyte, E.,
M. Rimpiläinen,
L. Lehtonen,
X. Zhang, and P. Toivanen.
2000.
Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains.
Infect. Immun.
68:3535-3540[Abstract/Free Full Text].
|
| 35.
|
Simon, G. L., and S. L. Gorbach.
1984.
Intestinal flora in health and disease.
Gastroenterology
86:174-193[Medline].
|
| 36.
|
Tannock, G. W.
1999.
Analysis of the intestinal microflora: a renaissance.
Antonie Leeuwenhoek
76:265-278.
|
| 37.
|
Toivanen, P.,
S. Koskimies,
K. Granfors, and E. Eerola.
1993.
Bacterial antibodies in HLA-B27+ healthy individuals.
Arthritis Rheum.
36:1633-1635[Medline].
|
| 37a.
| Vaahtovuo, J., P. Toivanen, and E. Eerola. Study of
murine microflora by cellular fatty acid analysis: effect of age and
mouse strains. Antonie Leeuwenhoek, in press.
|
| 38.
|
van de Merwe, J. P.,
J. H. Stegeman, and M. P. Hazenberg.
1993.
The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?
Antonie Leeuwenhoek
49:119-124.
|
| 39.
|
Weyand, C. M., and J. J. Goronzy.
1997.
Pathogenesis of rheumatoid arthritis.
Med. Clin. North Am.
81:29-55[CrossRef][Medline].
|
| 40.
|
Zhang, X.,
M. Rimpiläinen,
E. Simelyte, and P. Toivanen.
2000.
What determines arthritogenicity of bacterial cell wall? A study on Eubacterium cell wall-induced arthritis.
Rheumatology
39:274-282[Abstract/Free Full Text].
|
Infection and Immunity, April 2001, p. 2372-2377, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2372-2377.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Thompson, K., Burkholder, K., Patterson, J., Applegate, T. J.
(2008). Microbial Ecology Shifts in the Ileum of Broilers During Feed Withdrawal and Dietary Manipulations. Poult. Sci.
87: 1624-1632
[Abstract]
[Full Text]
-
Penn, D. J, Oberzaucher, E., Grammer, K., Fischer, G., Soini, H. A, Wiesler, D., Novotny, M. V, Dixon, S. J, Xu, Y., Brereton, R. G
(2007). Individual and gender fingerprints in human body odour. J R Soc Interface
4: 331-340
[Abstract]
[Full Text]
-
Stewart, J. A, Chadwick, V. S, Murray, A.
(2005). Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. J Med Microbiol
54: 1239-1242
[Abstract]
[Full Text]
-
Bell, A J G, Nicholls, R J, Forbes, A, Ellis, H J, Ciclitira, P J
(2004). Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut
53: 1801-1805
[Abstract]
[Full Text]
-
Gueimonde, M., Tolkko, S., Korpimaki, T., Salminen, S.
(2004). New Real-Time Quantitative PCR Procedure for Quantification of Bifidobacteria in Human Fecal Samples. Appl. Environ. Microbiol.
70: 4165-4169
[Abstract]
[Full Text]
-
Zoetendal, E. G., Collier, C. T., Koike, S., Mackie, R. I., Gaskins, H. R.
(2004). Molecular Ecological Analysis of the Gastrointestinal Microbiota: A Review. J. Nutr.
134: 465-472
[Abstract]
[Full Text]
-
Toivanen, P
(2003). Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis. Ann Rheum Dis
62: 807-811
[Abstract]
[Full Text]